PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1836269
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1836269
Chest Drainage Systems Market size was valued at US$ 1,878.98 Million in 2024, expanding at a CAGR of 5.2% from 2025 to 2032.
The chest drainage systems market is poised for continued growth, with innovations in digital monitoring, portable devices, and patient-centric designs leading the way. The rise of digital systems (with real-time monitoring, objective air-leak detection, data logging and alarms) is transforming care pathways. These devices enable more efficient, safer drainage, shorter hospital stays, and easier remote monitoring and opening avenues in telemedicine and digital health integration. Growing trends in outpatient recovery and long-term post-surgical care propel demand for compact, user-friendly, portable drainage systems ideal for use outside hospitals. Adoption of video-assisted thoracoscopic surgery (VATS) and percutaneous chest tube insertion helps reduce patient morbidity, hospital stay duration, and facilitates faster recovery, thereby supporting drainage device demand.
Chest Drainage Systems Market- Market Dynamics
Growing prevalence of respiratory and thoracic disorders
The rising prevalence of respiratory and thoracic disorders is a prime factor driving the global demand for chest drainage systems. Respiratory conditions such as chronic obstructive pulmonary disease (COPD), lung cancer, infectious respiratory diseases, and trauma-induced thoracic complications are some of the most common reasons patients require chest drainage. The increasing global burden of these diseases is closely linked to environmental pollution, tobacco use, aging populations, and changing lifestyles, which all contribute to higher rates of pulmonary and thoracic pathologies. Chest drainage systems are vital in managing life-threatening complications like pleural effusion, where fluid accumulates in the pleural cavity or pneumothorax, the build-up of air in the chest that can collapse the lung. These systems enable the safe and effective removal of air, blood, or fluids to restore normal breathing mechanics and prevent severe sequelae. As these respiratory and thoracic disorders become more frequent, especially in elderly and vulnerable populations, the demand for chest drainage solutions has risen suddenly. According to the report published in June 2025, by World Health Organization (WHO), around 81.7 million people in Europe were living with a chronic respiratory disease and 6.8 million were newly diagnosed each year. Thus, higher rates of respiratory and thoracic disorders, coupled with age demographics and risk exposures, are expected to increase demand for chest drainage systems, over the forecast period.
Chest Drainage Systems Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.2% over the forecast period (2025-2032)
Based on Product Type segmentation, Pleural Drainage Systems is predicted to show the maximum market share in the year 2024
Based on Indication segmentation, Pleural Effusion is the leading Indication in 2024
Based on End User segmentation, Hospitals are the leading Indication in 2024
Based on region, North America is the leading revenue generator in 2024
The Global Chest Drainage Systems Market is segmented on the basis of Product Type, Indication, Material Type, End User, and Region.
The market is divided into two categories based on Product Type: Pleural Drainage Systems, and Drainage Kits & Accessories. Pleural Drainage Systems are projected to hold the majority market share, driven by their critical role in treating pleural effusions and pneumothorax in various healthcare settings. Meanwhile, Drainage Kits & Accessories represent the fastest-growing segment in chest drainage market, rising acceptance in minimally invasive surgeries, which enhance efficiency and safety across both hospital and outpatient care environments.
The market is divided into six categories based on Indication: Pleural Effusion, Hemothorax, Spontaneous and Tension Pneumothorax, Cardiac Tamponade, Coronary Artery Bypass Grafting (CABG) Procedures, and Open-Heart Surgeries. Pleural Effusion, which holds the largest market share due to its high prevalence; Hemothorax, involving blood accumulation in the pleural cavity; Spontaneous and Tension Pneumothorax, requiring urgent drainage; Cardiac Tamponade, needing fluid removal to relieve pressure; Coronary Artery Bypass Grafting (CABG) Procedures; and Open-Heart Surgeries.
Chest Drainage Systems Market- Geographical Insights
North America is currently the largest market for chest drainage systems, accounting for a significant share in 2025. This dominance is attributed to advanced healthcare infrastructure, high adoption of innovative medical technologies, and strong regulatory support. The U.S., in particular, leads the region owing to the high prevalence of chronic respiratory diseases such as COPD and lung cancer, substantial healthcare expenditure, and a growing elderly population. Europe also holds a considerable share of the chest drainage systems market due to a high incidence of thoracic diseases and aging demographics. Countries like Germany, the UK, and France have robust hospital systems and ongoing initiatives to improve respiratory healthcare, which contributes to sustained use of chest drainage systems. The Asia-Pacific region is expected to register the highest growth rate during the forecast period. Rapid healthcare infrastructure development, increased awareness of respiratory health, and a rising number of surgical procedures are key factors pushing market expansion. In Latin America and the Middle East & Africa, the market is relatively smaller but growing steadily. Efforts to improve healthcare infrastructure, rising awareness of respiratory diseases, and increasing government healthcare expenditure are gradually expanding the market.
The competitive landscape of the chest drainage systems market is characterized by the presence of several major global players focused on innovation, technological advancement, and strategic expansion to capture growing demand worldwide. Teleflex Incorporated is known for its reliable, innovative chest drainage solutions, including automated systems with safety valves and features focused on preventing backflow and ensuring patient safety. B. Braun Melsungen AG is another dominant player, delivering high-quality, technologically advanced chest drainage devices widely used in thoracic surgery, pulmonology, and emergency care. The market competition centers on continuous R&D investment, strategic collaboration, product differentiation through technological integration (e.g., digital monitoring and portable systems), expanding distribution networks, and regulatory compliance. For instance, in May 2022, B. Braun Melsungen AG, a leader in infusion therapy and pain management, announced a collaboration agreement with Massachusetts General Hospital (MGH), aiming at co-developing cutting-edge clinical workflows, product design and training protocols.
In April 2024, Teleflex Incorporated, a global leader in medical technologies, has completed an 8,200-square-foot expansion of its extrusion capabilities at the Teleflex Medical OEM facility in Jaffrey, NH, U.S. This expansion represents an important achievement for the company and highlights its dedication to addressing the increasing worldwide demand for precision extrusion and access devices utilized in vital medical fields such as cardiology, neurology, radiology, and more.
In June 2021, Becton, Dickinson and Company (BD) declared it had received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the PeritX Peritoneal Catheter System for the drainage of symptomatic, recurrent non-malignant ascites.